Skip to main content
//empty //empty

On today’s TSX Breakouts report, there are 42 stocks on the positive breakouts list (stocks with positive price momentum), and 11 securities are on the negative breakouts list (stocks with negative price momentum).

Discussed today is a stock that is on the positive breakouts list. The share price has more than doubled year-to-date, rising 138 per cent, and this is on top of the 247 per cent gain realized in 2019. Growth has been pulled forward due to demand for the company’s telehealth services.

Interestingly, this Canadian company has attracted the interest and financial backing of one of the world’s richest people, Li Ka-shing, often referred to as the Warren Buffett of Asia.

Story continues below advertisement

The security highlighted today is WELL Health Technologies Corp. (WELL-T).

A brief outline is provided below that may serve as a springboard for further fundamental research when conducting your own due diligence.

The company

Vancouver-based WELL Health Technologies has four main business segments: 1) clinical/medical service provider with 20 medical centers located in B.C. (family practice and walk-in clinics) as well as telehealth services. This segment represents the largest contributor to the company’s total revenue, 2) electronic medical records (EMR) software provider to over 1,900 medical clinics across the country (management believes WELL is the third largest EMR supplier in the country. This high-margin business provides predictable, recurring revenue and represented roughly 17 per cent of total revenue in the first-quarter), 3) cybersecurity services aimed at protecting personal information with the increasing use of digital medical services, and 4) WELL Digital Health Apps (WDHA), a newly formed business unit.

Highlighted below are several attractive company characteristics that may help the share price continue to climb higher.

* Growth: Growth has been pulled forward helped by the company’s VirtualClinic+ national platform, which provides access to telehealth services via phone or video.

On May 15, the company reported record quarterly revenue of $10.2-million, up 38 per cent year-over-year. WELL reported an adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) loss of approximately $246,000, and an earnings per share loss of 2 cents.

Story continues below advertisement

On the first-quarter earnings call, the chief executive officer Hamed Shahbazi highlighted management’s core objectives for 2020, “One, achieving organic revenue growth in both its clinical and digital portfolios; two, continuing to follow a disciplined acquisition strategy, which includes the acquisition of or investment in accretive health clinics, OSCAR-based EMR service providers and other digital health care technology companies; three, increase our market penetration in the telehealth service sector; and four, achieve positive adjusted EBITDA in the second half of 2020.”

Mr. Shahbazi noted on the call the positive conversion of new patients to regular patients. Nearly 16 per cent of patients using VirtualClinic+ have had repeat visits with the same doctor.

“There are roughly five million unattached patients in Canada and many of them who are looking for a family physician, and many of them frustrated that they weren’t able to find one,” he said. “We are now seeing and that they are able to find physicians that they like on our platform. Thousands of patients are selecting doctors that they had a good experience with and going back to see them multiple times. We’re also finding that many patients have gone on to see doctors in person, inside clinics after seeing them online.”

He added, “Telehealth is also improving the long-term economics of our physical clinics. Going forward, we anticipate that physicians will be operating in a hybrid model of seeing patients in clinics as well as using telehealth.”

* Acquisition growth: WELL has the financial flexibility to continue to make acquisitions with over $24-million of cash on its balance sheet as at June 30. The company recently formed a new subsidiary, WELL Digital Health Apps Inc. (WDHA) that will focus on acquisition opportunities in the digital health apps market. In July, Shervin Bakhtiari was appointed to general manager of WDHA. In addition, the company hired Michael Goodman as head of acquisitions - Eastern Canada.

* Proven leadership and financial backing: Years ago, CEO Hamed Shahbazi founded TIO Networks Corp., a cloud-based bill payment processor that was acquired by PayPal Holdings Inc. (PYPL-Q) in 2017 for over $300-million.

Story continues below advertisement

According to Bloomberg, Hamed Shahbazi, owns over 14 per cent of WELL’s outstanding shares.

Interestingly, this small-cap Canadian stock caught the eye of Hong Kong business mogul Li Ka-shing, one of the richest people in the world and sometimes referred to as the Warren Buffett of Asia.

The company is expected to release its second-quarter financial results in the second half of this month.

Dividend policy

The company does not pay its shareholders a dividend.

Analysts' recommendations

Story continues below advertisement

There are 10 analysts that actively cover this small-cap stock with a market capitalization of $487-million, of which eight analysts have ‘buy’ recommendations and two analysts have ‘speculative buy’ recommendations.

The firms providing research coverage on the company are: Beacon Securities, Canaccord Genuity, Desjardins Securities, Echelon Wealth Partners, Eight Capital, Haywood Securities, Laurentian Bank Securities, Paradigm Capital, PI Financial and Stifel Canada.

Revised recommendations

Last month, six analysts revised their expectations – all higher.

  • Beacon’s Gabriel Leung raised his target price to $4.25 (the high on the Street) from $3.50.
  • Canaccord’s Doug Taylor tweaked his target price to $3.40 from $3.25.
  • Haywood’s Colin Healey increased his target price to $3.90 from $3.30.
  • Stifel’s Justin Keywood lifted his target price by 50 cents to $4.
  • PI Financial’s David Kwan adjusted his target price slightly higher to $3.50 from $3.35.
  • Laurentian’s Nick Agostino bumped his target price to $3.50 from $3.25.

Financial forecasts

The consensus revenue estimates are $43-million in 2020, up from $32.8-million reported in 2019, $59-million in 2021 and $75-million in 2022. The Street anticipates EBITDA to come in at a loss of $1-million in 2020, and to be positive $4-million in 2021. The Street is forecasting earnings per share to come in at a loss of over 6 cents in 2020, and a 2 cent loss in 2021.

Story continues below advertisement

The consensus revenue forecast has been stable for 2020 but has increased for 2021. For instance, three months ago, the Street was forecasting revenue of $50.6-million for 2021.


The stock can be valued using a number of methodologies including a sum-of-the-parts (SOTP) methodology, ascribing different valuation metrics to the individual business segments, or on a discounted cash flow (DCF) basis, or on an enterprise value-to-sales (EV/sales) multiple basis.

According to Bloomberg, the stock is trading an EV/sales multiple of 8.3 times the 2021 consensus estimate, and 6.4 times the 2022 consensus estimate.

The average one-year target price is $3.76, suggesting the share price is fully valued. Individual target prices are as follows in numerical order: $3.40 (from Canaccord’s Doug Taylor), four at $3.50, two at $3.90, $4, $4.10, and $4.25 (from Beacon’s Gabriel Leung).

Insider transactions

Story continues below advertisement

Year-to-date, there has not been any trading activity in the public market reported by insiders.

Chart watch

Year-to-date, the share price is up 138 per cent, this is on top of the 247 per cent gain in 2019!

The share price can be volatile. For instance, the share price dropped over 22 per cent between May 11 (closed at $3.27) and June 11 (closed at $2.53) but snapped back to a record closing high of $3.72 on July 31. On the final trading day of July, the share price jumped 3.6 per cent on high volume with over 2 million shares traded. The three-month historical daily average trading volume is approximately 1.37 million shares.

In terms of key resistance and support levels, the stock has an initial ceiling of resistance around $4. After that, the next major resistance level is around $4.50. Looking at the downside, there is strong technical support around $3, near the stock’s 50-day moving average (at $2.95). Failing that, there is technical support around $2.50.

TSX breakout stocks

Positive BreakoutsJuly 31 close
ABT-TAbsolute Software Corp $15.84
AGF-B-TAGF Management Ltd $5.29
AEM-TAgnico Eagle Mines Ltd $106.37
BTO-TB2Gold Corp $9.28
BDT-TBird Construction Inc $6.86
BLN-TBlackline Safety Corp. $6.15
CF-TCanaccord Genuity Group Inc $7.78
CWX-TCanWel Building Materials Group Ltd. $5.84
CG-TCenterra Gold Inc $16.80
GIB-A-TCGI Group Inc $95.67
CL-TCresco Labs Inc. $7.64
DRT-TDIRTT Environmental Solutions Ltd. $2.23
DCBO-TDocebo Inc. $44.00
DII-B-TDorel Industries Inc $9.69
DPM-TDundee Precious Metals Inc $10.06
ELD-TEldorado Gold Corp $16.83
FSV-TFirstService Corp $160.20
GLXY-TGalaxy Digital Holdings Ltd. $2.90
GGD-TGoGold Resources Inc $1.57
GSC-TGolden Star Resources Ltd. $5.98
H-THydro One Ltd. $28.54
IBG-TIBI Group Inc. $5.66
III-TImperial Metals Corp $3.01
INE-TInnergex Renewable Energy Inc $22.99
ITR-TIntegra Resources Corp. $5.64
IVN-TIvanhoe Mines Ltd $4.72
KNT-TK92 Mining Inc. $6.07
K-TKinross Gold Corp $12.50
KL-TKirkland Lake Gold Inc $73.30
MTA-TMetalla Royalty & Streaming Limited $10.63
NEO-TNeo Performance Materials Inc. $9.97
NPI-TNorthland Power Inc $36.70
ORE-TOrezone Gold Corp. $1.16
OLA-TOrla Mining Ltd. $5.70
PLC-TPark Lawn Corp. $25.05
PHO-TPhoton Control Inc. $2.32
TGZ-TTeranga Gold Corp $15.63
TFII-TTFI International Inc. $58.12
RNW-TTransAlta Renewables Inc $15.60
TCL-A-TTranscontinental Inc $15.44
WELL-TWell Health Technologies Corp. $3.72
WFT-TWest Fraser Timber Co Ltd $66.32
Negative Breakouts
BBU-UN-TBrookfield Business Partners LP $35.59
CWEB-TCharlotte's Web Holdings Inc. $4.65
CHR-TChorus Aviation Inc $2.36
FEC-TFrontera Energy Corp. $2.76
LB-TLaurentian Bank of Canada $26.55
LABS-TMediPharm Labs Corp. $1.04
OGI-TOrganigram Holdings Inc. $1.62
PSI-TPason Systems Inc $6.39
SU-TSuncor Energy Inc $21.07
VET-TVermilion Energy Inc $5.46
Y-TYellow Pages Ltd $7.97

Source: Bloomberg

The Breakouts file is a technical analysis screen intended to identify companies that are technically breaking out. In addition, this report highlights a company’s dividend policy, analysts’ recommendations, financial forecasts, and provides a brief technical analysis for a security to provide readers with more information.

If a stock appears on the positive breakouts list, this indicates positive price momentum, and that a company may be worthwhile for investors to look at the fundamentals in order to determine if the recent price strength is warranted and will continue. If a security appears on the negative breakouts list, this indicates negative price momentum, and may be indicative of either deteriorating fundamentals or perhaps indicates a buying opportunity.

Securities screened are from the S&P/TSX composite index, the S&P/TSX Small Cap index, as well as Canadian small cap stocks outside of these indexes that have a minimum market capitalization of $200-million.

A technical analysis screen does not replace fundamental analysis, but can help identify companies worth having a closer look at.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Report an error Editorial code of conduct
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies